Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q-21q26) or homologous translocation t(3;3) (q21;q26)

被引:37
作者
Reiter, E
Greinix, H
Rabitsch, W
Keil, F
Schwarzinger, I
Jaeger, U
Lechner, K
Worel, N
Streubel, B
Fonatsch, C
Mitterbauer, G
Kalhs, P
机构
[1] Univ Vienna, Dept Med 1, BMT Unit, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria
[3] Univ Vienna, Dept Blood Grp Serol, A-1090 Vienna, Austria
[4] Univ Vienna, Dept Med Hematol & Hemostaseolog 1, A-1090 Vienna, Austria
[5] Univ Vienna, Med Biol Inst, A-1090 Vienna, Austria
关键词
relapse; AML; BMT; chromosome; 3;
D O I
10.1007/s002770000158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Structural rearrangements of the long arm of chromosome 3 involving bands 3q21 and 3q26 and leading either to a paracentric inversion inv (3)(q21q26) or a translocation between both homologous chromosomes - t (3;3)(q21q26) -have been reported in patients with acute myelogenous leukemia (AML), myelodysplastic syndromes, myeloproliferative disorders, and chronic myelogenous leukemia in blast crisis. We describe three patients with de novo AML with these structural abnormalities who received multiple courses of conventional chemotherapy followed by unrelated donor (n=2) and autologous (n =1) bone marrow transplantation (BMT). All three patients had early relapse: patients 1 and 2 had relapse 69 days and 306 days after BMT, respectively, and patient 3 immediately after autologous BMT. Despite further chemotherapy, they died without achieving another remission. These findings, together with other recorded similar cases, show that AML with structural abnormalities of the long arm of chromosome 3 as described has an extremely poor prognosis even with the most potent anti-leukemic treatment modalities.
引用
收藏
页码:374 / 377
页数:4
相关论文
共 21 条
[1]  
BENNETT JM, 1985, ANN INTERN MED, V103, P626
[2]   BONE-MARROW TRANSPLANTS MAY CURE PATIENTS WITH ACUTE-LEUKEMIA NEVER ACHIEVING REMISSION WITH CHEMOTHERAPY [J].
BIGGS, JC ;
HOROWITZ, MM ;
GALE, RP ;
ASH, RC ;
ATKINSON, K ;
HELBIG, W ;
JACOBSEN, N ;
PHILLIPS, GL ;
RIMM, AA ;
RINGDEN, O ;
ROZMAN, C ;
SOBOCINSKI, KA ;
VEUM, JA ;
BORTIN, MM .
BLOOD, 1992, 80 (04) :1090-1093
[3]  
BITTER MA, 1985, BLOOD, V66, P1362
[4]  
FONATSCH C, 1994, LEUKEMIA, V8, P1318
[5]   A POSSIBLE CORRELATION BETWEEN THE DEGREE OF KARYOTYPE ABERRATIONS AND THE RATE OF SISTER CHROMATID EXCHANGES IN LYMPHOMA LINES [J].
FONATSCH, C ;
SCHAADT, M ;
KIRCHNER, H ;
DIEHL, V .
INTERNATIONAL JOURNAL OF CANCER, 1980, 26 (06) :749-756
[6]   DETECTION OF ENGRAFTMENT AND MIXED CHIMERISM FOLLOWING BONE-MARROW TRANSPLANTATION USING PCR AMPLIFICATION OF A HIGHLY VARIABLE REGION-VARIABLE NUMBER OF TANDEM REPEATS (VNTR) IN THE VONWILLEBRAND-FACTOR GENE [J].
GAIGER, A ;
MANNHALTER, C ;
HINTERBERGER, W ;
HAAS, O ;
MAROSI, C ;
KIER, P ;
EICHINGER, S ;
FUNOVIC, M ;
LECHNER, K .
ANNALS OF HEMATOLOGY, 1991, 63 (04) :227-228
[7]   Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors [J].
Greinix, HT ;
Reiter, E ;
Keil, F ;
Fischer, G ;
Lechner, K ;
Dieckmann, K ;
Leitner, G ;
Schulenburg, A ;
Hoecker, P ;
Haas, OA ;
Knoebl, P ;
Mannhalter, C ;
Fonatsch, C ;
Hinterberger, W ;
Kalhs, P .
BONE MARROW TRANSPLANTATION, 1998, 21 (07) :673-678
[8]   CLINICAL, HEMATOLOGICAL AND CYTOGENETIC FEATURES IN 24 PATIENTS WITH STRUCTURAL REARRANGEMENTS OF THE Q-ARM OF CHROMOSOME-3 [J].
GRIGG, AP ;
GASCOYNE, RD ;
PHILLIPS, GL ;
HORSMAN, DE .
BRITISH JOURNAL OF HAEMATOLOGY, 1993, 83 (01) :158-165
[9]   The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial [J].
Grimwade, D ;
Walker, H ;
Oliver, F ;
Wheatley, K ;
Harrison, C ;
Harrison, G ;
Rees, J ;
Hann, I ;
Stevens, R ;
Burnett, A ;
Goldstone, A .
BLOOD, 1998, 92 (07) :2322-2333
[10]   ACUTE-LEUKEMIA WITH STRUCTURAL REARRANGEMENTS OF CHROMOSOME-3 [J].
HORSMAN, DE ;
GASCOYNE, RD ;
BARNETT, MJ .
LEUKEMIA & LYMPHOMA, 1995, 16 (5-6) :369-377